This report describes an efficient method to clone PCR products exploi
ting endogenous Escherichia coli enzymatic activities. PCR products ar
e engineered to contain terminal sequences identical to sequences at t
he two ends of a linearized vector. PCR products and vector DNA are th
en simply co-transfected into E. coli strain JC8679, obviating the req
uirement for enzymatic treatment of the PCR product or in vitro ligati
on. The high rate of homologous recombination in this strain results i
n efficient incorporation of the insert into the vector, a process we
refer to as in vivo cloning (IVC).